Daphnetin contributes to allergen-induced Th2 cytokine expression and type 2-immune responses in atopic dermatitis and asthma-Reference-Cited by-同舟云学术

Daphnetin contributes to allergen-induced Th2 cytokine expression and type 2-immune responses in atopic dermatitis and asthma

Published:2022 Issue:23 Volume:13 Page:12383-12399
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Zhang Yi¹,Qu Lu¹,Sun Yun¹^ORCID,Lin YuPing¹^ORCID,Zeng Jing²,He LiXia³,Li Xiucun⁴,Gu Wen¹,Nie Jian¹,Yu Xiaoling⁵,Tong XiaoYun⁶^ORCID,Huang Feng¹⁷^ORCID

Affiliation:

1. School of Pharmaceutical Science, Department of Pharmacology of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China

2. Department of Chinese Medicine, College of Pharmacy, Jinan University, Guangzhou 510632, China

3. The Second Affiliated Hospital of Wannan Medical College, Wuhu 241001, China

4. Qi-Lu Hospital of Shandong University, Jinan 250012, China

5. The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650021, China

6. The First Affiliated Hospital of Yunnan University of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650021, China

7. Yunnan Key Laboratory of Southern Medicinal Utilization, College of Traditional, Chinese Medicine, Yunnan University of Chinese Medicine, Kunming 650021, China

Abstract

Daphnetin reduced atopic dermatitis, asthma and PCA symptom. Daphnetin inhibited activation of mast cell. Daphnetin might be a candidate for the treatment of AD.

Funder

National Natural Science Foundation of China

Yunnan Provincial Science and Technology Department

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/FO/D2FO02518C

Reference70 articles.

1. Current pharmaceutical developments in atopic dermatitis

2. BCG for the prevention and treatment of allergic asthma